Semiconductor & Electronics Technology: 2018

Friday, 26 October 2018

Global qPCR Reagents Market – Application, Development, Size, Growth, Share, Analysis and Forecast 2024

Qualitative polymerase chain reaction (qPCR) reagent is the mixture used in the qPCR technique to quantitate DNA sequence in a sample to synthesis new strands of DNA. It is also known as real-time polymerase chain reaction. The global qPCR reagents market is growing at significant rate due to mounting occurrence of infectious diseases and genetic disorders, technological improvement and speedy progression in geriatric population. The market has witnessed high demand for qPCR core kits over the last few years, due to low prices of core kits.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/qpcr-reagents-market/request-sample

The qPCR reagents market is highly regulated and requires intensive capital for the entry. Moreover, the competition among the players is increasing as the demand for technologically advanced products is increasing.

Geographically, North America is the largest qPCR reagents market as the region is home to large number of industry players. Some of the other factors leading to the growth of the North American market are elevated dispersion of qPCR technologies among end users, mounting public & private grant to magnify the application base of qPCR, continuing product advancements, and constant decrease in the average price of genome sequencing.

Asia-Pacific is observed to witness the fastest growth in the market as the region comprises of largest population. In addition, escalating occurrence of infectious disease and genetic disorder, expanding geriatric population, growing initiatives to enhance awareness associated to gene-based disease treatment, mounting frequencies of criminal cases, growing intensity of global life sciences industries, and mounting private and public support to enlarge innovative digital PCR technologies, are also creating a positive impact on the qPCR reagents industry growth in the region.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/qpcr-reagents-market

Key players in the industry are investing in the development of innovative and advance quantitative polymerase chain reaction reagents products, which is strengthening their position in the market. Thermo Fisher Scientific, Bio-Rad Laboratories Inc., and Qiagen N.V. together accounted major share of the qPCR reagents market. For instance, In March 2018, Thermo Fisher Scientific Inc., acquired IntegenX Inc., to enhance its product portfolio. IntegenX Inc, is a company which offers a speedy DNA platform for usage in forensics and law implementation applications.

In addition, in April 2018, QIAGEN N.V. launched QIAstat-Dxâ an integrated molecular analysis of common syndromes as tested for in syndromes in infections, oncology and other diseases in Europe. Thermo Fisher Scientific Inc., Affymetrix, Inc., Bio-Rad Laboratories, Inc., Takara Bio Inc., F. Hoffman-La Roche Ltd., Promega Corporation, Qiagen N.V., Agilent Technologies, Inc., Sigma-Aldrich Corporation, and Quanta Biosciences, Inc. are some of the key players offering qPCR reagents products.

About VynZ Research :

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | Twitter | Facebook | Google+

Thursday, 25 October 2018

Global Guidewires Market – Application, Analysis, Size, Trends and Forecast 2024

Guidewires is a flexible wire inserted into the confined space as to guide instrument. It is mainly used in vascular intervention. The global guidewires market is growing at significant rate, due to escalating acceptance of minimally invasive surgery and increasing healthcare expenditure. The market has witnessed high demand for surgical guidewires over the last few years due to mounting regulatory directive executed for the prevention of healthcare related infection and escalating number of surgical treatment.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/guidewires-market/request-sample

Globally, the manufacturing companies are extensively involved in research and development of products in order to cater various medical procedures. Moreover, manufacturing companies have to abide strict regulatory requirements. However, rapid technological advancements have created immense opportunity for the manufacturers to leverage the market potential.

Geographically, North America is the largest guidewires market as in the region there is robust presence of key OEMs. In addition, the huge target patient population base those experiencing minimally invasive surgical procedures, mounting prevalence of lifestyle associated diseases, and escalating acceptance of more sophisticated wires are driving the growth of the North American guidewires market. Moreover, escalating geriatric population, mounting occurrence of cardiovascular diseases, and boosting reimbursement among developed countries are also up surging growth of the North American market.

Asia-Pacific is observed to witness fastest growth in the market. In addition, multiplying number of surgical and diagnostic procedures, boosting healthcare expenditure, escalating geriatric population, mounting prevalence of lifestyle associated diseases and modernization & expansion of healthcare infrastructure are also creating a positive impact on the guidewires industry growth in the region.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/guidewires-market

Key players in the guidewires market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2018, Medtronic announced advanced SynergyTLIF workflow, an integrated fully navigated procedure with less surgical procedures for lumbar spine surgery. Moreover, in February 2017, Medtronic received FDA and CE clearance for DxTerity Diagnostic Angiography Catheter line and transradial-specific products such as TRAcelet compression device, DxTerity TRA, and InTRAkit access kit in its coronary product portfolio.

Medtronic PLC, Boston Scientific, C.R. Bard, Terumo Corporation, Abbott Laboratories, B. Braun, Johnson & Johnson, Stryker Corporation, Olympus Corporation, Angiodynamics, and Cardinal Health are the key players offering guidewires.

About VynZ Research :

Contact

VynZ Research USA

Wednesday, 10 October 2018

Globle Technical News - Pyrogen Testing Market - LAL Tests, Rabbit Tests, and In Vitro Tests, Trends and Forecast to 2024

Pyrogen testing is the compulsory phase in the manufacturing process to eliminate or deactivate probable bacterial contaminants. Its products are used for the treatment and diagnostic purposes. The global pyrogen testing market is growing at a significant rate, due to speedy growth in pharmaceutical and biotechnology industries and mounting number of novel drug launches. Different products contributed to the pyrogen testing market size. The market has witnessed high demand for kits and reagents in the coming years due to mounting implementation of kit-based testing and recurrence purchase of kits and reagents as compared to instruments

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/pyrogen-testing-market/request-sample

Globally, the manufacturing companies trying to enter the pyrogen testing market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest pyrogen testing market as in the region the investment by government in healthcare and pharmaceutical industry is increasing. Research and development of novel drugs, mounting burden of chronic diseases, and upsurge in a number of biologic products are also up surging growth of the North American pyrogen testing market. For instance, according to GLOBOCAN in the U.S. approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/pyrogen-testing-market

Asia-Pacific is observed to witness fastest growth in the market, due to mounting research and development of novel drugs. In addition, mounting occurrence of chronic diseases, and mounting healthcare expenditure are also creating a positive impact on the pyrogen testing market growth in the region.

Key players in the pyrogen testing market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In March 2018, Associates of Cape Cod, Inc., introduced a new, swift endotoxin recognition kit, Pyrosate, an easy-to-use Limulus Amebocyte Lysate (LAL) gel-clot test which enables rapid testing. Associates of Cape Cod, Inc., Merck KGaA, Thermo Fisher Scientific, Inc., GenScript, Charles River Laboratories, Inc., Ellab A/S, Lonza Group, and WUXI Pharmatech (Cayman) Inc. are the key players offering pyrogen testing.

About VynZ Research :

Contact

VynZ Research USA

Global Intraoperative Imaging Market - Neurosurgery, Orthopedic, Analysis and Forecast to 2024

The global intraoperative imaging market is predicted to grow at 6.1% CAGR during the forecast period with the market size reaching USD 2.6 billion by 2024. Different products such as mobile c-arms, intraoperative computed tomography, intraoperative magnetic resonance imaging, and intraoperative ultrasound are majorly contributing to the intraoperative imaging market size. The market has witnessed significant demand for mobile c-arm over the last few years due to the mounting occurrence of cardiovascular diseases, and expanding number of orthopedic surgeries.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/intraoperative-imaging-market/request-sample

Key factors hindering the growth of the intraoperative imaging market are the high cost of the intraoperative imaging device, strict regulatory requirement, and lack of skilled professionals. In addition, risks and complications using intraoperative devices is also having a negative impact on the growth of the intraoperative devices market

Geographically, North America is the largest intraoperative imaging market as the region the demand for the minimally invasive procedure is increasing and well-developed healthcare infrastructure. In addition, the mounting occurrence of chronic diseases and lifestyle associated diseases, and expanding geriatric population are also fueling the growth of the North American intraoperative imaging market. For instance, according to GLOBOCAN in the U.S., approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/intraoperative-imaging-market

Asia-Pacific is observed to witness significant growth in the intraoperative imaging market during the forecast period, as the region comprises of a large population, government initiatives in establishing innovative technologies, and refining healthcare infrastructure. Moreover, intensifying healthcare expenditure, expanding the geriatric population, growing occurrence of orthopedic disorder, demand for refined medical service, and mounting occurrence of chronic diseases and lifestyle associated diseases are also facilitating the significant growth of Asia-Pacific intraoperative imaging industry.

Market players in the intraoperative imaging industry are investing capital to develop technologically advanced systems. In November 2017, Ziehm Imaging strengthens its position in mobile C-arm imaging by the introduction of CMOS line, which completes CMOS portfolio from compact mini C-arms to powerful high-end devices. Medtronic Plc, Ziehm Imaging GmbH, General Electric Company, Koninklijke Philips NV, Toshiba Corporation, Siemens AG, Brainlab AG, and Shimadzu Corporation are some of the key players offering solutions for intraoperative imaging.

About VynZ Research :

Contact

VynZ Research USA

Monday, 8 October 2018

Global Image-Guided Surgery Devices Market - X-Ray Fluoroscopy, Development, Trends and Forecast to 2024

The global image-guided surgery devices market is predicted to grow at 7.1% CAGR during the forecast period with the market size reaching USD 6.3 billion by 2024. Image-guided surgery is also known as navigation surgery, it visually correlates intraoperative anatomy with preoperative CT scan. Image-guided surgery devices are used for guiding surgeons during the surgery. It enhances accuracy during the surgery, decreases procedure time, reduces complexity, and insignificant surgical scar.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/image-guided-surgery-devices-market/request-sample

Key factors hindering the growth of the image-guided surgery devices market are the high cost of imaging technique, and strict regulatory requirement. In addition, the lack of awareness is also having a negative impact on the growth of the image-guided surgery devices market.

Geographically, North America is the largest image-guided surgery devices market as the region is home to a large number of industry players and has a high frequency of acceptance of novel technologies. In addition, expanding geriatric population, escalating demand of non-invasive surgery, obtainability of skilled professionals, mounting healthcare awareness, intensifying demand of minimally invasive surgery, the mounting occurrence of neurological disorder, and escalating healthcare expenditure are also fueling the growth of the North American image-guided surgery devices market.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/image-guided-surgery-devices-market

Asia-Pacific is observed to witness significant growth in the image-guided surgery devices market during the forecast period, as the region comprises of a large population, and refining healthcare infrastructure. Moreover, expanding the geriatric population, intensifying demand for minimally invasive surgery, mounting healthcare awareness, and speedily increasing medical tourism are also facilitating the significant growth of Asia-Pacific image-guided surgery devices industry.

Market players in the image-guided surgery devices industry are investing capital to develop technologically advanced systems. In June 2018, Royal Philips acquired EPD Solutions, to improve its product portfolio of image-guided procedures for cardiac arrhythmias. Siemens AG, Koninklijke Philips N.V, Medtronic Plc, Stryker Corporation, Hitachi, Ltd., Varian Medical Systems, Inc., Smith & Nephew plc, KARL STORZ GmbH & Co. KG., Zimmer Holdings, Inc., and General Electric are some of the key players offering solutions for image-guided surgery devices.

About VynZ Research :

Contact

VynZ Research USA

Global E-Clinical Solutions Market - On-Demand/ Web-Based, On-Premise, and Cloud-Based, Growth Factor, Trends and Forecast to 2024

The global e-clinical solutions market is predicted to grow at 11.9% CAGR during the forecast period with the market size reaching USD 10.4 billion by 2024. Different types of solutions such as electronic data capture (EDC) and clinical data management system (CDMS), clinical trial management system (CTMS), clinical analytics platforms, and randomization and trial supply management are majorly contributing to the e-clinical solutions market size. The market has witnessed significant demand for electronic data capture and clinical data management system over the last few years due to mounting demand for improved data standardization.

Download free Report Sample at: https://www.vynzresearch.com/healthcare/e-clinical-solutions-market/request-sample

Key factors hindering the growth of the e-clinical solutions market are the high cost of implementation, the low adoption rate of the software, lack of high-speed broadband facility and long approval time. In addition, the dearth of skilled professionals is also having a negative impact on the growth of the market.

Geographically, North America is the largest e-clinical solutions market as the region is home to a large number of industry players. In addition, mounting demand for improved data standardization and upsurge in spends on research and development by pharmaceutical and biotechnology companies are also fueling the growth of the North American e-clinical solutions market.

Asia-Pacific is observed to witness significant growth in the e-clinical solutions market during the forecast period, as the region comprises of a large population, easy patient recruitment, and the existence of less strict regulatory strategies. Moreover, mounting government sponsoring to strengthen clinical trials, the less operational cost for clinical trials, intensifying healthcare expenditure, increasing outsourcing of clinical trials, and growing number of pharmaceutical companies and CROs are also facilitating the significant growth of Asia-Pacific e-clinical solutions industry.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/e-clinical-solutions-market

Market players in the e-clinical solutions industry are investing capital to develop technologically advanced systems. In February 2018, OmniComm Systems, Inc. acquired Algorics, to enhance its product portfolio in a clinical analytics solution. Oracle Corporation, PAREXEL International Corporation Medidata Solutions, Inc., DATATRAK International, Inc., eClinical Solutions, Inc., Bio-Optronics, Inc., ERT, MaxisIT Inc., and OmniComm Systems, Inc. are some of the key players offering solutions for e-clinical solutions.

About VynZ Research :

Contact

VynZ Research USA

Global Laboratory Information System (LIS) Market - Standalone and Integrated, Web-Based, On-Premise, Analysis and Forecast to 2024

The global laboratory information system market is predicted to grow to USD 3.2 billion by 2024, growing at a CAGR of 8.5% during the forecast period. Different products such as integrated an standalone are majorly contributing to the laboratory information system market size. Laboratory information system (LIS) is a software solution which manages the obtaining, handling, and storage of information created by laboratories. It helps to simplify laboratory processes to decline specimen handling time, enhance turnaround time, and upsurge productivity.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/laboratory-information-system-market/request-sample

Key factors hindering the growth of the laboratory information system market are the high cost of LIS, interoperability and technical issues. In addition, the dearth of skilled professionals and requirement of specialized laboratory units for chemistry, hematology, and microbiology is also having a negative impact on the growth of the market.

Geographically, North America is the largest laboratory information system market as in the region the occurrence of chronic diseases is increasing, regulatory mandates in the U.S., and mounting personalized medicine initiatives. In addition, mounting initiatives by government and industry players in healthcare IT, expanding need for quality cancer diagnosis, the mounting requirement for the integrated healthcare system, and escalating healthcare spending are also fueling the growth of the North American laboratory information system market.

Expllore Full Report Description at: https://www.vynzresearch.com/healthcare/laboratory-information-system-market

Asia-Pacific is observed to witness significant growth in the laboratory information system market during the forecast period, as the region comprises of a large population, cancer diagnostic initiatives, mounting requirement for the integrated healthcare system, escalating awareness of LIS, and mounting EHR adoption. Moreover, intensifying healthcare expenditure, government schemes to increase healthcare IT, refining healthcare infrastructure, and mounting occurrence of chronic diseases are also facilitating the significant growth of Asia-Pacific laboratory information system industry.

Market players in the laboratory information system industry are investing capital to develop technologically advanced systems. In April 2018, SCC Soft Computer and Australian Red Cross Blood Service have introduced an implementation study to assess SCC’s laboratory and genetics information management systems. Cerner Corporation, SCC Soft Computer, Mckesson Corporation, Compugroup Medical AG, EPIC Systems Corporation, Computer Programs and Systems, Inc., International Business Machines, and Orchard Software Corporation are some of the key players offering solutions for laboratory information system.

About VynZ Research :

Contact

VynZ Research USA

Sunday, 7 October 2018

Global MRI Guided Neuro Ablation Devices Market - MRI Guided RF Ablation System, Dvelopment, Trends and Forecast to 2024

The global MRI guided neuro ablation devices market is predicted to grow at 5.3% CAGR during the forecast period with the market size reaching USD 175.6 million by 2024. Different products such as MRI guided RF ablation system, MRI guided focused ultrasound systems, and MRI guided laser therapy system are majorly contributing to the MRI guided neuro ablation devices market size. The market has witnessed significant demand for MRI guided RF ablation system over the last few years due to mounting awareness of minimally invasive surgery.

Download Free Sample Copy of Research Report: https://www.vynzresearch.com/healthcare/mri-guided-neuro-ablation-devices-market/request-sample

Key factors hindering the growth of the MRI guided neuro ablation devices market are limited awareness among patient about the treatment brain tumor in developing countries, high cost, and a limited workforce. In addition, the dearth of skilled professionals is also having a negative impact on the growth of the market.

Geographically, North America is the largest MRI guided neuro ablation devices market as the region geriatric population is increasing and favorable reimbursements policies. In addition, the mounting occurrence of cancer, escalating healthcare expenditure, changing lifestyle, and escalating awareness of minimally invasive surgery are also fueling the growth of the North American MRI guided neuro ablation devices market. For instance, according to GLOBOCAN in the U.S., approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/mri-guided-neuro-ablation-devices-market

Asia-Pacific is observed to witness significant growth in the MRI guided neuro ablation devices market during the forecast period, as the region comprises of a large population and expanding the geriatric population. Moreover, mounting occurrence cancer, refining healthcare infrastructure, mounting awareness of minimally invasive surgery, and escalating healthcare expenditure are also facilitating the significant growth of Asia-Pacific MRI guided neuro ablation devices industry.

Market players in the MRI guided neuro ablation devices industry are investing capital to develop technologically advanced systems. In April 2018, Medtronic Plc launched the Visualase, an MRI-guided laser ablation system in Europe. The system offers advanced MRI-guided laser ablation technology which is used in neurosurgery procedures. Medtronic Plc, Insightec Ltd, Monteris Medical Inc, Boston Scientific Corporation, AngioDynamics Inc, and MRI Intervention Inc. are some of the key players offering solutions for MRI guided neuro ablation devices.

About VynZ Research :

Contact

VynZ Research USA

Wednesday, 19 September 2018

Global Computerized Physician Order Entry (CPOE) Systems Market Growth Trends,Type ,Revenue, Research Approach and Forecast to 2018-2024

Computerized physician order entry (CPOE) is an electronic entry process which helps healthcare practitioners to go through medical orders into computer systems which are within a hospital setting. It helps to reduce errors related to handwriting and time taken for order completion.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/computerized-physician-order-entry-cpoe-market/request-sample

Lack of skilled professionals, high cost and time consuming installation cost, lack of awareness among physicians and interoperability issues are the major challenges for the growth of computerized physician order entry market.

Geographically, North America is the largest computerized physician order entry market as in the region the government initiatives for installation of CPOE systems is increasing. Increasing investments for better healthcare facilities, increasing occurrence of chronic and lifestyle associated diseases, elevated adoption of advanced technology and mounting need for integrated healthcare are also up surging growth of the North American computerized physician order entry market.

Asia-Pacific is observed to witness the fastest growth in the market, due to mounting demand for better healthcare. In addition, increasing occurrence of chronic and lifestyle associated diseases, improving healthcare infrastructure, alertness about the benefits of computerized patient data management systems and expanding geriatric population are also creating a positive impact on the computerized physician order entry market growth in the region.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/computerized-physician-order-entry-cpoe-market

Key players in the computerized physician order entry market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In January 2018, Allscripts signed a definitive agreement to acquire Practice Fusion to offer the comprehensive and high performing health information technology and solutions.

In September 2010, RelayHealth, a McKesson’s connectivity business, launched Connected Orders, a workflow solution which links ambulatory-care physicians with hospital, laboratories, imaging centers and patients to computerize the test ordering process. Allscripts Healthcare Solutions, Inc., EPIC Systems, Mckesson Corporation, Athenahealth, Inc., General Electric Company, Siemens AG, Carestream Health, Medical Information Technology, Inc., Cerner Corporation, Royal Philips and eClinicalWorks are the key players offering computerized physician order entry solutions.

About VynZ Research :

Contact

VynZ Research USA

165 Broadway, 23rd Floor,

New York City, New York – 10006

United States of America

Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | Twitter | Facebook | Google+

Monday, 27 August 2018

Global 3D Printing Market in Healthcare – Analysis and Forecast (2018-2024)

3D printing technology produces and manufactures customizes medical equipment, medical devices, prosthetics and products. The global 3D printing market in healthcare is growing at significant rate, due to mounting need for implants. Different types contributed to the 3D printing market in healthcare size. The market has witnessed high demand for surgical guides over the last few years due to mounting usage of the digitally focused process for precise surgical preparation.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/3d-printing-market-in-healthcare/request-sample

Socio-ethical concerns related to the usage of 3D-printed products, strict regulatory procedure for the approval of the 3D printed medical devices, high cost associated with the advanced 3D printers, patent issues related to 3D printing and lack of trained professionals are the major challenges for the growth of 3D printing market in healthcare.

Globally, the manufacturing companies trying to enter the 3D printing market in healthcare are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest 3D printing in healthcare market as in the region the demand for organ transplants is increasing. In addition, highly developed healthcare infrastructure, expanding geriatric population, mounting need for implants, technological improvements, conferences and trade, mounting number of patients with dental problems and hearing loss and government & private assets to progress innovative 3D printing technologies & applications are also up surging growth of the North American 3D printing market in healthcare.

Asia-Pacific is observed to witness fastest growth in the market, due to mounting adoption of 3D printing medical devices. In addition, establishment of novel 3D printing research, education and training centers, expanding geriatric population, improving healthcare infrastructure, mounting number of patients with dental problems and hearing loss, large population base and mounting healthcare expenditure are also creating a positive impact on the 3D printing market in healthcare growth in the region.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/3d-printing-market-in-healthcare

Key players in the 3D printing market in healthcare are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In June 2018, 3D Systems introduced DMP Flex 100 and DMP Dental 100 3D printers, to provide versatility and material for entrance level metal 3D printing and dental applications.

In addition, in February 2018, EnvisionTEC launched 3D printing orthodontic models to create clear thermoformed aligners. Stratasys Ltd., Renishaw plc, Concept Laser GmbH, EnvisionTEC GmbH, 3T RPD Ltd, Materialise NV, 3D Systems Corporation, Arcam AB, Prodways Group and EOS GmbH Electro Optical Systems are the key players offering 3D printing in healthcare.

About VynZ Research :

Contact

VynZ Research USA

Friday, 24 August 2018

Global Biosurgery Market – Trends, Demands, Size, Share, Growth, Application, Analysis and Forecast (2018-2024)

Biosurgery is the combination of techniques and surgical techniques to decrease post and intra-operative complications. The global biosurgery market is growing at significant rate, due to expanding geriatric population and mounting number of surgeries. Different product and services contributed to the biosurgery market size. The market has witnessed high demand for bone-graft substitutes in the coming years due to mounting usage of bone-graft substitutes in various types of orthopedic surgeries as they decrease surgical time.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/biosurgery-market/request-sample

High cost of biosurgery products & escalating cost of surgical procedures, lack of skilled professionals for effectual use of biosurgery products, and strict regulatory framework are the major challenges for the growth of biosurgery market.

Globally, the manufacturing companies trying to enter the biosurgery market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest biosurgery market as in the region the geriatric population is increasing. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.

Mounting number of trauma injuries, mounting number of surgical procedures, mounting healthcare expenditure, mounting occurrence of chronic diseases and lifestyle associated diseases and advance technological amendment are also up surging growth of the North American biosurgery market. For instance, according to Centers for Disease Control and Prevention in 2012, approximately 117 million people in the U.S. had one or the more chronic conditions.

Explore Full Report Sample at: https://www.vynzresearch.com/healthcare/biosurgery-market

Asia-Pacific is observed to witness fastest growth in the market, due to expanding geriatric population and refining healthcare infrastructure. In addition, mounting healthcare expenditure, mounting occurrence of chronic diseases and lifestyle associated diseases, escalating number of surgical procedures, and mounting demand for effectual blood loss management are also creating a positive impact on the biosurgery market growth in the region.

Key players in the biosurgery market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In April 2018, Medtronic PLC received FDA approval of Infuse Bone Graft. It is used with spine implants composed of polyetheretherketone in oblique lateral interbody fusion and anterior lumbar interbody fusion procedures. Baxter International, Inc., Medtronic, PLC., Hemostasis, LLC, B.Braun Melsungen AG, Cohera Medical Inc., C.R. Bard, Sanofi, Johnson & Johnson, Getinge Group and Integra Lifesciences Holdings Corporation are the key players offering biosurgery.

About VynZ Research :

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | Twitter | Facebook | Google+

Global Transradial Access Devices Market – Analysis and Forecast (2018-2024)

Transradial access devices are utilized in the endovascular or catheterization procedure to execute the analysis and treatment of any kind of the arterial disease. Its kit includes various minor components such as catheters, accessories, sheaths and sheath introducers and guidewires. The global transradial access devices market is growing at significant rate, due to mounting occurrence of lifestyle associated diseases and technological improvements. Different products contributed to the transradial access devices market size. The market has witnessed high demand for catheters over the last few years due to budding amount of interventional and angiography procedures.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/transradial-access-devices-market/request-sample

The lack of skilled professionals, high costs involved in the placement and maintenance of vascular access devices, risks associated with radial access devices, and product recalls and failures are the major challenges for the growth of transradial access devices market.

Globally, the manufacturing companies trying to enter the transradial access devices market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North American is the largest transradial access devices market as in the region the occurrence of cardiovascular disease is increasing. For instance, according to Centers of Disease Control and Prevention (CDC), in the U.S. approximately 610,000 people die every year due to heart disease. Moreover, according to CDC, approximately 370,000 people die annually due to coronary heart disease in the U.S. It is the most common type of heart disease in the U.S.

Mounting occurrence of cancer, upsurge in clinical trials and research for vascular access devices, expanding geriatric population, improved healthcare infrastructure, and increasing number of conferences, and workshops are also up surging growth of the North American transradial access devices market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/transradial-access-devices-market

Key players in the transradial access devices market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2018, Medtronic Plc announced advanced SynergyTLIF workflow, an integrated fully navigated procedure with less surgical procedures for lumbar spine surgery. Moreover, in February 2017, Medtronic Plc received FDA and CE clearance for DxTerity Diagnostic Angiography Catheter line and transradial-specific products such as TRAcelet compression device, DxTerity TRA, and InTRAkit access kit.

Becton, Dickinson and Company, Merit Medical Systems, Terumo Corporation, Teleflex Incorporated, Boston Scientific Corporation, Ameco Medical, Smiths Medical, Nipro Medical Corporation, Medtronic PLC, Angiodynamics, Inc, Edward Lifesciences Corporation, and Oscor Inc. are the key players offering transradial access devices.

About VynZ Research :

Global Diagnostic Imaging Market - Popular Trends & Technological Advancements to Watch Out for Near Future 2024

Diagnostic imaging is a procedure to generate image of internal and external body parts for clinical purpose. It has its application in several medical fields such as neurology, cardiology, orthopedics, and oncology. The global diagnostic imaging market is growing at significant rate, due to mounting occurrence chronic diseases and boosting number of diagnostic centers. Different product contributed to the diagnostic imaging market size. The market has witnessed high demand for x-ray imaging systems in the coming years due to mounting demand for mobile x-ray system, expanding geriatric population and mounting occurrence of diseases and injuries.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/diagnostic-imaging-market/request-sample

Mounting implementation of refurbished diagnostic imaging systems, lack of skilled professionals, elevated price of diagnostic imaging systems, disapproving healthcare reforms in the U.S., and technological restrictions associated with standalone systems are the major challenges for the growth of diagnostic imaging market.

Globally, the manufacturing companies trying to enter the diagnostic imaging market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest diagnostic imaging market as in the region the occurrence of chronic diseases is increasing. For instance, according to GLOBOCAN in the U.S. approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012. Expanding geriatric population, technological developments in diagnostic imaging modalities and mounting inclination for minimally invasive treatment are also up surging growth of the North American diagnostic imaging market.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/diagnostic-imaging-market

Asia-Pacific is observed to witness fastest growth in the market, due to mounting occurrence of chronic diseases. In addition, expanding geriatric population, mounting medical tourism, improving healthcare infrastructure and mounting healthcare expenditure are also creating a positive impact on the diagnostic imaging market growth in the region.

Key players in the diagnostic imaging market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In February 2016, Carestream introduced digital X-ray technology that delivers rapid access to diagnostic images. Carestream’s Cone Beam CT System helps physicians to assess players’ injuries during the matches. It is specially designed for orthopaedic imaging. GE Healthcare, Hitachi Ltd., Siemens AG, Samsung Medison, Carestream Health, Koninklijke Philips N.V., Esaote S.P.A, Shimadzu Corporation, Toshiba Corporation, and Fujifilm Holdings Corporation are the key players offering diagnostic imaging.

About VynZ Research :

Global Hernia Repair Market - Popular Trends & Technological Advancements to Watch Out for Near Future 2024

Hernia is a medical condition where an organ or fatty tissue protrudes out via a weak point. Hernia repair is a surgical procedure performed for the management of a hernia. Laparoscopic repair surgery and open tension-free repair surgery are the major methods for hernia repair. The global hernia repair market is growing at significant rate, due to mounting occurrence hernia, expanding geriatric population and technological improvement. Different products contributed to the hernia repair market size. The market has witnessed high demand for mesh in the coming years due to higher cost of meshes contrasted to mesh fixators.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/hernia-repair-market/request-sample

Elevated price of mesh repair, lack of skilled professionals, accessibility of less massive approaches and lengthy waiting period in developed countries are the major challenges for the growth of hernia repair market. In addition, complications related to hernia repair are also hindering the growth of the hernia repair market. For instance, according to FDA, pain, infection, hernia recurrence, adhesion, obstruction, bleeding, and a hole in neighboring tissues or organs are the complications related to hernia repair.

Globally, the manufacturing companies trying to enter the hernia repair market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest hernia repair market as in the region the acceptance of hernia repair is increasing. In addition, expanding geriatric population, presence of large pool of hernia patients, mounting healthcare expenditure, technological improvement, and efficient and favorable healthcare system are also up surging growth of the North American hernia repair market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/hernia-repair-market

Asia-Pacific is observed to witness fastest growth in the market, due to expanding geriatric population. In addition, mounting medical tourism, improving healthcare infrastructure and mounting healthcare expenditure are also creating a positive impact on the hernia repair market growth in the region.

Key players in the hernia repair market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2017, Integra LifeSciences Holdings Corporation launched SurgiMend MP a tissue-building solutions for complex abdominal hernia repair.

In addition, in April 2017, Becton, Dickinson and Company acquired Bard, to provide innovative healthcare solutions and to improve its product portfolio. B. Braun Melsungen AG, Becton, Dickinson and Company, Getinge AB, Johnson & Johnson, Cook Group Inc., Medtronic PLC., Integra Lifesciences Holdings Corporation, W. L. Gore & Associates, Via Surgical and Herniamesh are the key players offering repair products.

About VynZ Research :

Thursday, 23 August 2018

Global Cerebrospinal Fluid Management Market - Popular Trends & Technological Advancements to Watch Out for Near Future 2024

Cerebrospinal fluid (CSF) management is clear and colorless body fluid found in the brain and spine which acts as a support for the brain, providing basic mechanical and immunological protection to the brain inside the skull. The global cerebrospinal fluid management market is growing at significant rate, due to mounting occurrence hydrocephalus and expanding geriatric population. Different product contributed to the cerebrospinal fluid management market size. The market has witnessed high demand for shunts in the coming years due to mounting number of shunting procedures and expanding geriatric population.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/cerebrospinal-fluid-management-market/request-sample

Lack of skilled professionals and high cost of shunts are the major challenges for the growth of cerebrospinal fluid management market. Complications associated with CSF shunts are hindering the growth of the cerebrospinal fluid management market. For instance, shunt malfunction, shunt infection, under drainage, subdural hematoma, seizures, multiloculated hydrocephalus and over drainage are the complications associated with the CSF shunts.

Globally, the manufacturing companies trying to enter the cerebrospinal fluid management market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest cerebrospinal fluid management market as in the region the occurrence of hydrocephalus increasing. Mounting funding for hydrocephalus research, mounting occurrence of neurological disorders, expanding geriatric population, mounting demand for minimally invasive procedure, rapid technological advancement and the initiate of organizations are also up surging growth of the North American cerebrospinal fluid management market. For instance, according to the U.S. Census Bureau, in 2012 approximately 43.1 million people were aged 65 years and older in the U.S. and is expected to reach 83.7 million in 2050.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/cerebrospinal-fluid-management-market

Asia-Pacific is observed to witness fastest growth in the market, due to mounting occurrence of hydrocephalus and increasing awareness about neurological diseases. In addition, improving healthcare infrastructure, mounting medical tourism, mounting demand for minimally invasive procedure, mounting occurrence of stroke disease, expanding geriatric population and mounting healthcare expenditure are also creating a positive impact on the cerebrospinal fluid management market growth in the region.

Key players in the cerebrospinal fluid management market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2016, Medtronic PLC, received FDA clearance for StrataMR valves and shunts, for treatment of patients with hydrocephalus and cerebrospinal fluid disorders.

In addition, in April 2017, Medtronic PLC, voluntary recalls all unused StrataMR valves and shunts. Medtronic PLC, Spiegelberg GmbH & Co. Kg, Deltasurgical, Integra Lifesciences Holdings Corporation, Natus Medical Incorporated, G.SURGIWEAR LTD, B. Braun Melsungen, Dispomedica GmbH, SOPHYSA, Moller Medical GmbH, and Wellong Instruments Co., Ltd are the key players offering cerebrospinal fluid management.

About VynZ Research :

Contact

VynZ Research USA

Global Fertility Test Market - Popular Trends & Technological Advancements to Watch Out for Near Future 2024

Fertility test is a process by which fertility is accessed. The global fertility test market is growing at significant ate, due to Escalating first-time pregnancy age, introduction of innovative fertility monitors with high-level precision. Different products contributed to the fertility test market size. The market has witnessed high demand for ovulation predictor kits in the coming years due minimal charge as contrasted to fertility monitors, and less price and high efficiency.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/fertility-test-market/request-sample

High price of fertility testing monitors, untested precision of urine-based ovulation monitors and reduced precision of ovulation prediction kits are the major challenges for the growth of fertility test market.

Globally, the manufacturing companies trying to enter the fertility test market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest fertility test market as in the region the usage of fertility monitoring device for contraception is increasing.

Escalating first-time pregnancy age, mounting awareness about the benefits of ovulation monitors through social media, e-commerce sites and marketing campaigns, and mounting occurrence of polycystic ovary syndrome are also up surging growth of the North American fertility test market. For instance, according to the Centre for Disease Control and Prevention (CDC) report on National Vital Statistics Report 2015, in the U.S., the mean age of mother at first birth was 25.8 years in 2012, and it has increased to 26 years in 2013.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/fertility-test-market

Asia-Pacific is observed to witness fastest growth in the market, due to mounting occurrence of lifestyle disorders. In addition, mounting funding for the improvement of fertility and ovulation monitors and mounting number of manufacturers and suppliers of fertility testing are also creating a positive impact on the fertility test market growth in the region.

Key players in the fertility test market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In December 2016, Prestige Brands Holdings, Inc. has entered into a definitive agreement to acquire C.B. Fleet Company, to enhance its product portfolio in feminine care and other over-the-counter healthcare products.

In July 2016, Ava launched Ava Bracelet, a fertility tracking sensor bracelet, to detect the fertility days during a women’s cycle. Advacare Pharma, Biozhena, Fertility Focus, Prestige Brands Holdings, AVA, SPD Swiss Precision Diagnostics, Fairhaven Health, Taidoc, Babystart, Hilin Life Products, Church & Dwight, Sensiia and Geratherm Medical are the key players offering fertility test.

About VynZ Research :

Wednesday, 22 August 2018

Global Healthcare/Medical Simulation Market – Analysis and Forecast (2018-2024)

Healthcare simulation is a method of imitating a real-life medical state to reveal and educate healthcare professionals. It is guiding healthcare professionals through usage of innovative technology. The global healthcare/medical simulation market is growing at significant rate, due to advantages of simulation over conventional learning, mounting need for minimally invasive treatments. Different product and services contributed to the healthcare/medical simulation market size. The market has witnessed high demand for anatomical models over the last few years due to mounting primary care services, and scarcity of healthcare professionals.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/healthcaremedical-simulation-market/request-sample

Globally, the manufacturing companies trying to enter the healthcare/medical simulation market are required to maintain stringent regulatory standards. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest medical simulation market as in the region the number of healthcare professionals is increasing. Easiness of availability to technologies, elevated acceptance of simulation by medical universities and training centers, improved healthcare infrastructure, and entrenched distribution channels are also up surging growth of the North American healthcare/medical simulation market.

Asia-Pacific is observed to witness fastest growth in the market, as the region comprises of large population base. In addition, mounting awareness on simulation learning, refining healthcare infrastructure, budding focus on the global medical simulation players, mounting healthcare expenditure and mounting emphasis on patient safety are also creating a positive impact on the healthcare/medical simulation market growth in the region.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/healthcaremedical-simulation-market

Key players in the healthcare/medical simulation market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2018, 3D Systems launched Simbionix ANGIO Tab Pro endovascular simulator for step-by-step teaching of endovascular interventions. In addition, in June 2017, CAE Healthcare introduced CAE Juno, a recently invented clinical skills manikin for nursing programs, in International Nursing Association for Clinical Simulation and Learning (INACSL) annual conference in Washington.

CAE and Laerdal Medical accounted the major share in the market. CAE, Simulab Corporation, 3D Systems Inc., Mentice AB, Gaumard Scientific Company, Simulaids Inc., Kyoto Kagaku Co., Ltd, Limbs & Things Ltd., Laerdal Medical and Medaphor are the key players offering healthcare/medical simulation.

About VynZ Research :

Contact

VynZ Research USA